HELP (Helus Pharma) Common Stock: $492.10 Mil (As of Mar. 2026)


HELP Helus Pharma Inc HELP
33 GF Score
Price $6.44
! 2 Warning Signs
View Full Analysis

What is Helus Pharma Common Stock?

Helus Pharma HELP +3.40% 33 Common Stock is $492.10 Mil as of Mar. 2026. GuruFocus rates HELP with a GF Score™ of 33/100. The stock has 2 warning signs investors should review.

Helus Pharma's quarterly common stock increased from Sep. 2025 ($353.59 Mil) to Dec. 2025 ($482.73 Mil) and increased from Dec. 2025 ($482.73 Mil) to Mar. 2026 ($492.10 Mil).

Helus Pharma's annual common stock increased from Mar. 2024 ($328.51 Mil) to Mar. 2025 ($345.31 Mil) and increased from Mar. 2025 ($345.31 Mil) to Mar. 2026 ($492.10 Mil).

Helus Pharma Common Stock Historical Data

* Premium members only.

The historical data trend for Helus Pharma's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Helus Pharma Common Stock Chart

Helus Pharma Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Common Stock
Get a 7-Day Free Trial 113.30 116.93 328.51 345.31 492.10

Helus Pharma Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 345.31 333.15 353.59 482.73 492.10
HELP
33GF Score
Helus Pharma Inc HELP
Common Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Helus Pharma Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of $492.10 Mil mean?
Helus Pharma (HELP) has a Common Stock of $492.10 Mil as of Mar. 2026. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Helus Pharma and its competitors.
Is Helus Pharma's Common Stock too high?
Helus Pharma's current Common Stock is $492.10 Mil. Overall, Helus Pharma has a GF Score™ of 33/100, reflecting its overall financial health beyond just this single metric.
How does Helus Pharma's Common Stock compare to VRTX and REGN?
Helus Pharma's Common Stock of $492.10 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Biotechnology company?
A good Common Stock depends on the Biotechnology industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Helus Pharma and its competitors. Helus Pharma's current Common Stock is $492.10 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Helus Pharma stock overvalued right now?
Helus Pharma (HELP) has a current Common Stock of $492.10 Mil. The current Common Stock is $492.10 Mil. Helus Pharma's overall GF Score™ is 33/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Helus Pharma (HELP), the current Common Stock is $492.10 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Helus Pharma Business Description

Other Exchanges R7E:GermanyHELP:Canada
Address 100 King Street West, Suite 5600, Toronto, ON, CAN, M5X 1C9
Helus Pharma Inc, the commercial operating name of Cybin Inc, is a clinical-stage pharmaceutical company focused on developing proprietary neuroactive compounds, referred to as NSAs, which are synthetic molecules designed to target serotonin pathways. The company's programs are aimed at treating mental health conditions such as depression and anxiety. Its pipeline includes HLP003, which is in clinical development for the adjunctive treatment of depressive disorder, and HLP004, which is in clinical development for generalized anxiety disorder. The company also conducts research on additional investigational compounds.
33GF Score

Get the complete analysis for HELP

Common Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$6.44
Price